Immunobiology of primary sclerosing cholangitis
Open accessThe DOI matches its Crossref record; 165 of the 165 references it cites were found in a registry or an index.
Abstract
Primary sclerosing cholangitis (PSC) is a chronic inflammatory progressive cholestatic liver disease. Genetic risk factors, the presence of autoantibodies, the strong clinical link with inflammatory bowel disease, and associations with other autoimmune disorders all suggest a pivotal role for the immune system in PSC pathogenesis. In this review, we provide a comprehensive overview of recent immunobiology insights in PSC. A particular emphasis is given to immunological concepts such as tissue residency and knowledge gained from novel technologies, including single-cell RNA sequencing and spatial transcriptomics. This review of the immunobiological landscape of PSC covers major immune cell types known to be enriched in PSC-diseased livers as well as recently described cell types whose biliary localization and contribution to PSC immunopathogenesis remain incompletely described. Finally, we emphasize the importance of time and space in relation to PSC heterogeneity as a key consideration for future studies interrogating the role of the immune system in PSC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, PSCs exhibit some signs of an autoimmune disease directed against BECs, and evidence points toward intense crosstalk between BECs, neutrophils, macrophages, and T and B cells [174, 175].”
From Inflammation and immunity in liver homeostasis and disease: a nexus of hepatocytes, nonparenchymal cells and immune cells (2025) · doi:10.1038/s41423-025-01313-7 · cites this paper as [174]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Kennedy, L. L., Hargrove, L. A., Demieville, J., Karstens, W., Jones, H. F., DeMorrow, S., Meng, F., Invernizzi, P., Bernuzzi, F., Alpini, G. D., et al. (2018) · Hepatology · doi:10.1002/hep.29898 · Cited by 72
RetractedBile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
Jia, W., Xie, G., & Jia, W. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.119 · Cited by 1,924 · cited 2×
“[93,94] Intestinal inflammation and associated gut dysbiosis are thought to disrupt bile acid homeostasis, [112,113] a feature described in patients with PSC. [114,115] More-over, these bile acids have been shown to modulate the balance of Th17 cells and Tregs in experimental models.”
Bile acid metabolites control TH17 and Treg cell differentiation
Hang, S., Paik, D., Yao, L., Kim, E., Trinath, J., Lu, J., Ha, S., Nelson, B. N., Kelly, S. P., Wu, L., et al. (2019) · Nature · doi:10.1038/s41586-019-1785-z · Cited by 1,457 · cited 1×
“[112,116] Recently, right-sided colonic biopsies from patients with PSC-IBD and IBD analyzed by bulk RNAseq, scRNAseq, and flow cytometry identified distinct features of intestinal inflammation in PSC-IBD compared with IBD where PSC-IBD inflammation was characterized by the presence of IL-17+FoxP3+…”
Neutrophil diversity and plasticity in tumour progression and therapy
Jaillon, S., Ponzetta, A., Di Mitri, D., Santoni, A., Bonecchi, R., & Mantovani, A. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0281-y · Cited by 1,285
Broad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICB
Groh, V., Rhinehart, R., Secrist, H., Bauer, S., Grabstein, K. H., & Spies, T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6879 · Cited by 1,028
Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches
Guilliams, M., Bonnardel, J., Haest, B., Vanderborght, B., Wagner, C., Remmerie, A., Bujko, A., Martens, L., Thoné, T., Browaeys, R., et al. (2022) · Cell · doi:10.1016/j.cell.2021.12.018 · Cited by 985 · cited 1×
“[9,10] Also here, spatial resources are now available on end-stage disease PSC livers.”
Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis
Klose, C. S. N., & Artis, D. (2016) · Nature Immunology · doi:10.1038/ni.3489 · Cited by 951
Fuchs, A., Vermi, W., Lee, J. S., Lonardi, S., Gilfillan, S., Newberry, R. D., Cella, M., & Colonna, M. (2013) · Immunity · doi:10.1016/j.immuni.2013.02.010 · Cited by 907
Primary sclerosing cholangitis – a comprehensive review
Karlsen, T. H., Folseraas, T., Thorburn, D., & Vesterhus, M. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.07.022 · Cited by 868
The burgeoning family of unconventional T cells
Godfrey, D. I., Uldrich, A. P., McCluskey, J., Rossjohn, J., & Moody, D. B. (2015) · Nature Immunology · doi:10.1038/ni.3298 · Cited by 805
Cited by
(2025) · doi:10.1038/s41423-025-01313-7 · Cited by 97
CCL24 and Fibrosis: A Narrative Review of Existing Evidence and Mechanisms
Greenman, R., & Weston, C. J. (2025) · Cells · doi:10.3390/cells14020105 · Cited by 16
Aseem, S. O., Wang, J., Kalaiger, M. F., Way, G. W., Zhao, D., Tai, Y., Gurley, E. C., Zeng, J., Wang, X., Cowart, L. A., et al. (2025) · Hepatology Communications · doi:10.1097/hc9.0000000000000748 · Cited by 8
Azad, A. I., Gutiérrez, F., & Gores, G. J. (2025) · Cells · doi:10.3390/cells15010069 · Cited by 5
The dynamic landscape of cholestatic liver disease
Gores, G. J., & Malhi, H. (2025) · Hepatology · doi:10.1097/hep.0000000000001298 · Cited by 1
Metadata
- Authors
- Cornillet, M., Geanon, D., Bergquist, A., & Björkström, N. K.
- Affiliations
- Karolinska University Hospital (SE)
- Corresponding author
- Björkström, Niklas K.
- Venue
- Hepatology
- Published
- 2024-09-02
- Volume
- 82
- Issue
- 4
- Pages
- 911-926
- ISSN
- 0270-9139 (ISSN-L)
- 1527-3350
- PMC
- PMC12440291
- OpenAlex
- W4402215835
- Cited by
- 20
- References
- 161
- Citations by year
- 2026: 11 · 2025: 9
- FWCI
- 1.44
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Hepatology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- European Commission (HORIZON2020)
- Cancerfonden
- Karolinska Institutet
- Vetenskapsrådet
- Novo Nordisk Fonden (NNF21OC0067824)
- Center for Innovative Medicine
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Keywords
- primary sclerosing cholangitis, immunopathogenesis, immune cell composition, single-cell RNA sequencing, spatial transcriptomics, autoantibodies, inflammatory bowel disease, autoimmune disease, cholestatic liver disease
- MeSH terms
- Humans, Cholangitis, Sclerosing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Immunobiology of primary sclerosing cholangitis. https://app.cochat.ai/papers/10.1097/hep.0000000000001080
- The paper
- Cornillet, M., Geanon, D., Bergquist, A., & Björkström, N. K. (2025). Immunobiology of primary sclerosing cholangitis. Hepatology. https://doi.org/10.1097/hep.0000000000001080
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.